SIRT1 and diabetic kidney disease: On the one hand, activation of the sirtuins family (especially SIRT1, 2, 3, 6) of NAD+-dependent deacetylases can inhibit mitochondrial oxidative stress, improve mitochondrial biogenesis, alleviate inflammation and reduce apoptosis, thereby preventing the progression of DKD.